Xiaosheng Shao - China Biologic Independent Director

Director

Mr. Xiaosheng Shao is Independent Director of China Biologic Products, Inc. In addition to his roles with us, Mr. Sean Shao currently serves as independent director and member of the audit committee of Trina Solar Limited, an integrated solarpower products manufacturer and solar system developer listed on the NYSE, since January 2015, independent director and chairman of the audit committee of Jumei International Holding Ltd., an ecommerce company listed on NYSE since May 2014 LightInTheBox Holdings Co. Ltd., an ecommerce company listed on NYSE since June 2013 and UTStarcom Holdings Corporationration, a provider of broadband equipment and solutions listed on NASDAQ since October 2012, and independent director and chairman of the nominating committee of Agria Corporationrationration, an agricultural company listed on NYSE since November 2008. He served as the chief financial officer of Trina Solar Limited from 2006 to 2008. In addition, Mr. Shao served from 2004 to 2006 as the chief financial officer of ChinaEdu Corporationrationration, an educational service provider, and of Watchdata Technologies Ltd., a Chinese security software company. Prior to that, Mr. Shao worked at Deloitte Touche Tohmatsu CPA Ltd. for approximately a decade. Mr. Shao received his masters degree in health care administration from the University of California at Los Angeles in 1988 and his bachelors degree in art from East China Normal University in 1982. Mr. Shao is a member of the American Institute of Certified Public Accountants. since 2008.
Age 59
Tenure 16 years
Phone(86) 10 6598 3222
Webwww.chinabiologic.com

China Biologic Management Efficiency

The company has return on total asset (ROA) of 5.82 % which means that it generated a profit of $5.82 on every $100 spent on assets. This is normal as compared to the sector avarege. Similarly, it shows a return on stockholder's equity (ROE) of 9.25 %, meaning that it created $9.25 on every $100 dollars invested by stockholders. China Biologic's management efficiency ratios could be used to measure how well China Biologic manages its routine affairs as well as how well it operates its assets and liabilities.

Similar Executives

Showing other executives

DIRECTOR Age

James PlummerCadence Design Systems
73
Joseph ZimmelFactSet Research Systems
67
Susan BostromCadence Design Systems
57
Malcolm FrankFactSet Research Systems
54
Michael HarrisGetty Images Holdings
43
Laurie SiegelFactSet Research Systems
64
George ScaliseCadence Design Systems
81
Scott BilleadeauFactSet Research Systems
58
Mark AdamsCadence Design Systems
53
Carmen ChangCoursera
73
Mary WilderotterCadence Design Systems
63
Siew ChoyFactSet Research Systems
54
Lee ShavelFactSet Research Systems
53
Roger SiboniCadence Design Systems
63
James McGonigleFactSet Research Systems
57
Michael WhettenDatadog
N/A
Joseph LairdFactSet Research Systems
69
Alberto SangiovanniVincentelliCadence Design Systems
70
Young SohnCadence Design Systems
62
Scott MillerFactSet Research Systems
46
Scott SandellCoursera
56
China Biologic Products Holdings, Inc. engages in the research, development, manufacture, and sale of human plasma-based biopharmaceutical products to hospitals and inoculation centers in the Peoples Republic of China. China Biologic Products Holdings, Inc. is headquartered in Beijing, the Peoples Republic of China. China Biologic operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. China Biologic Products (CBPO) is traded on NASDAQ Exchange in USA and employs 2,246 people.

Management Performance

China Biologic Products Leadership Team

Elected by the shareholders, the China Biologic's board of directors comprises two types of representatives: China Biologic inside directors who are chosen from within the company, and outside directors, selected externally and held independent of China. The board's role is to monitor China Biologic's management team and ensure that shareholders' interests are well served. China Biologic's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, China Biologic's outside directors are responsible for providing unbiased perspectives on the board's policies.
Min Fang, Director
Zhijing Liu, Corporate VP
Ming Yang, CFO
Joseph Chow, Independent Director
Gang Yang, Corporate VP and General Manager of Guizhou Taibang
Xiaosheng Shao, Independent Director
Ming Yin, Sr. Corporate VP and Corporate Secretary
Zhijun Tong, Independent Director
Yungang Lu, Independent Director
Wenfang Liu, Independent Director
Wai Yeung, Independent Director
David Li, Director
David Gao, Chairman of the Board and Presidentident, CEO
Xiaoying Gao, Executive Chairman, CEO and Pres

China Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is China Biologic a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards China Biologic in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, China Biologic's short interest history, or implied volatility extrapolated from China Biologic options trading.

Pair Trading with China Biologic

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if China Biologic position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in China Biologic will appreciate offsetting losses from the drop in the long position's value.
The ability to find closely correlated positions to Carnival could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Carnival when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Carnival - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Carnival to buy it.
The correlation of Carnival is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Carnival moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Carnival moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Carnival can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey.
You can also try the Piotroski F Score module to get Piotroski F Score based on the binary analysis strategy of nine different fundamentals.

Other Consideration for investing in China Stock

If you are still planning to invest in China Biologic Products check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the China Biologic's history and understand the potential risks before investing.
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Portfolio Analyzer
Portfolio analysis module that provides access to portfolio diagnostics and optimization engine
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA
ETFs
Find actively traded Exchange Traded Funds (ETF) from around the world
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets